SCOPUS
Egyptian Journal of Immunology
Modern Commercial Press, Egypt
Egyptian Journal of Immunology is an academic journal published by Modern Commercial Press (Egypt). Identifiers: ISSN 1110-4902, eISSN 2090-2506. Indexed in SCOPUS. Metrics: CiteScore 1.1, SJR 0.252. tlooto lists 66 papers from this journal.
CiteScore
1.10
Scopus citation metric
SJR
0.252
SCImago rank
SNIP
-
Source normalized impact
Percentage rank
-
JIF percentile rank
Journal profile
- ISSN
- 1110-4902
- eISSN
- 2090-2506
- Abbreviation
- -
- Publisher
- Modern Commercial Press
- Country
- Egypt
Web of Science categories
No Web of Science category data available.
Scopus ASJC categories
2700 General Medicine
Papers in this journal
Recent papers
- Evaluation of CD19+ CD24+CD27 B cell and serum level of interleukin 10 and interleukin 35 in patients with systemic lupus erythematosus.
2026 · 1 citations
- Serum progranulin: A potential marker of SLE activity.
2026
- Diagnostic value of serum lipocalin-2 in Egyptian patients with inflammatory bowel disease: A case-control study.
2026 · 1 citations
- Trichinella spiralis - induced modulation of IFN-γ and TGF-β shapes host immunity to support chronic infection.
2026
- Peripheral blood inflammatory cell ratios derived from complete blood count as predictors of multiple sclerosis disease activity and severity.
2026
Most cited papers
- The role of circulating cell-free DNA and its integrity as a biomarker for diagnosis of breast cancer using ALU (247/115) bP sequences
2023 · 2 citations
- Role of CD36 expression on circulating monocytes subsets in children on regular hemodialysis
2021 · 2 citations
- Immune-Endocrine crosstalk in hypertensive overweight men: Dysregulation of IL-17 and IL-40-mediated inflammatory pathways
2026 · 1 citations
- The role of CTLA-4, epiregulin and PD-1 in women with polycystic ovarian syndrome
2025 · 1 citations
- Serum oncostatin M is a potential biomarker of disease activity and infliximab response in inflammatory bowel disease
2025 · 1 citations